jpost.com
Cancer Immunotherapy Breakthrough
Tel Aviv University researchers discovered a mechanism that prevents the immune system from attacking tumors, potentially leading to more effective immunotherapies.
English
Israel
HealthCancerResearchTreatmentMedicineImmunology
Tel Aviv UniversityNature Communications
Prof. Carmit LevyProf. Yaron CarmiAvishai Maliah
- What are the next steps for the research team?
- The research team is now working to translate their findings into a potential treatment for human cancer patients, offering a new treatment option for those with limited treatment responses.
- How did the researchers initially stumble upon this discovery?
- The discovery was accidental, stemming from research on UV radiation's effects on the immune system, and showed that Ly6a is overexpressed in melanoma and colon cancer.
- What is the main discovery of the Tel Aviv University researchers?
- Researchers at Tel Aviv University discovered that the protein Ly6a, overexpressed in tumors, acts as a brake on T cells, preventing the immune system from attacking cancer cells.
- What were the results of the treatment with antibodies targeting Ly6a?
- Antibodies targeting Ly6a led to significant tumor shrinkage in animal models, even in cancers resistant to other immunotherapies, suggesting a potential new treatment.
- What is the potential significance of this research for cancer treatment?
- The breakthrough could significantly improve immunotherapy, as about 50% of cancer patients don't respond to current treatments; this research offers a potential solution for them.